Search the Archive

Skin Cancer Vaccine #281252

CBS Evening News for Wednesday, Nov 24, 1982
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio) Incring. cases of melanoma skin cancer reported annually noted.
REPORTER: Dan Rather

(Atlanta, Georgia) Melanoma victim Mark Kelly noted participating in experimental program focusing on vaccine treatment for disease. [KELLY - attributes his life to program.] Doctors William Cassel's and Douglas Murray's vaccine development explained. [Virginia GRAY - notes new lease on life with vaccine.] [CASSEL - hopes to extend disease-free interval for patients.] [GRAY - comments.] No. in Emory Univ. program surviving melanoma mentioned. [KELLY - appreciates life more now.]
REPORTER: Wyatt Andrews

Andrews, Wyatt;
Rather, Dan

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.